India's most comprehensive portal on pharmaceutical News, Tenders, Patents, Notifications, Projects, Stocks, Drugs & Medicines

US FDA lifts clinical hold of Intellia Therapeutics’ MAGNITUDE phase 3 trial of nex-z for patients with transthyretin amyloidosis with cardiomyopathy

Join Pharma | Login

	Editorial


	DEFINITION ON OTC DRUGS
	Wednesday, March 4, 2026
	A robust regulatory framework for over-the-counter (OTC) medicines has been long overdue in the country. It is almost nine years since the Union Health Ministry constituted a subcommittee on the issue.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	US FDA lifts clinical hold of Intellia Therapeutics’ MAGNITUDE phase 3 trial of nex-z for patients with transthyretin amyloidosis with cardiomyopathy
17:00 [IST]	Japan’s MHLF approves reimbursement for Novocure’s Optune Lua to treat non-small cell lung cancer
16:30 [IST]	PCI fixes theme for Pharma Anveshan, 2026; to discuss future synergy in pharma ecosystem
16:00 [IST]	CHMP adopts positive opinion on Moderna’s mRNA combination vaccine ‘mCOMBRIAX’ against influenza, Covid-19
15:00 [IST]	Ipsen receives CHMP’s positive opinion on Ojemda for treating monotherapy of children with relapsed or refractory BRAF-altered paediatric low-grade glioma
14:30 [IST]	DCGI issues alert on certain batch of Sanofi India's insulin formulation Lantus SoloStar after reported theft

more news >>

TOP NEWS


08:00 [IST]	CDSCO to replace SUGAM Portal with new digital platform to boost regulatory system digitisation
08:00 [IST]	KPRDO demands pan-India implementation of COA on drug purchases by wholesalers from pharma manufacturers
08:00 [IST]	Pharmacists raise alarm as govt proposes pharmacist-free Jan Aushadhi Kendras
08:00 [IST]	BDCDA proposes K-DTTP to monitor medicines at first point of entry
08:00 [IST]	NPPA fixes retail price of 20 new drugs
08:00 [IST]	CDSCO soon to engage QCI certified notified bodies to augment drug regulatory audit capacity: DCGI

more news >>

YESTERDAY'S NEWS


17:45 [IST]	MicrobioTx study detects toxic chemicals in 93% urban blood samples
17:40 [IST]	Medanta unveils initiative to combat chronic respiratory diseases, aims to shift focus from seasonal alarm over air pollution to sustained year-long vigilance
17:35 [IST]	FTCCI hosts a full-day workshop on Resilient Minds – Thriving Businesses, focus on legal protection of doctors
17:30 [IST]	Avio inks shareholders deal with Huwel; Targets large-scale public TB diagnostics opportunity
17:25 [IST]	Cardiology experts highlight growing incidence of Bradycardia, need for early diagnosis and intervention
17:20 [IST]	Sun Pharma’s campaign urges Indians to prioritise heart health through daily actions

more news >>

INTERVIEW


Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana

Past Interviews...

	What's New?

iguratimod 25 mg tablet nebivolol 5 mg +telmisartan 40 mg tab hydroxyzine 25 mg oint methyl salicylate 450 gm clindamycin 100 mg + clotrimazole 200 mg etc...

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers